Our results are further supported by in vitro and in vivo studies in preclinical PCA models where Dyn2 inhibition resulted in a significant decrease in cell proliferation, and motility and invasion in both androgen-responsive and androgen-resistant PCA cell lines. Here, DNM2 is linked to posterior cortical atrophy.